Biodesix (BDSX) Assets Average (2020 - 2026)

Biodesix (BDSX) has 7 years of Assets Average data on file, last reported at $91.1 million in Q1 2026.

• Quarterly Assets Average fell 0.75% year-over-year to $91.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.1 million (down 0.75% YoY) and the FY2025 annual result came in at $92.4 million, down 5.92% from the prior year.
• Assets Average grew to $91.1 million in Q1 2026, from $88.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $109.3 million in Q3 2024 to a low of $68.4 million in Q2 2022.
• A 5-year average of $86.8 million and a median of $88.1 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average plunged 41.77% — and 2024, when it surged 32.95%.
• Tracing BDSX's Assets Average over 5 years: stood at $78.1 million in 2022, then rose by 19.08% to $92.9 million in 2023, then grew by 7.59% to $100.0 million in 2024, then retreated by 11.9% to $88.1 million in 2025, then climbed by 3.36% to $91.1 million in 2026.
• The last three Assets Average figures came in at $91.1 million (Q1 2026), $88.1 million (Q4 2025), and $88.2 million (Q3 2025), per Business Quant data.